Literature DB >> 3723581

Subclass distribution of IgG and IgA responses to rubella virus in man.

A Stokes, C A Mims, R Grahame.   

Abstract

Monoclonal anti-subclass antibodies were used in a micro-ELISA method to determine rubella-specific IgG subclass antibodies in serum from 22 subjects who had acute rubella or had been vaccinated, from 10 infants with congenital rubella, and in serum and synovial fluid samples from 21 patients with chronic arthritis. In nearly all samples IgG1 was the only type of IgG antibody detected. In acute infections it was present within 10 days of the onset of the rash. IgG4 antibody was detected in sera from two immune individuals. Rubella-specific IgA1 subclass antibody was detected by the same technique in sera from 6 of 12 subjects with acute rubella as early as 3 days but not later than 28 days after the appearance of the rash.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3723581     DOI: 10.1099/00222615-21-4-283

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Specific IgG subclass antibody in rubella virus infections.

Authors:  H I Thomas; P Morgan-Capner
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

2.  Rubella-specific IgG subclass concentrations in sera using an enzyme-linked immunosorbent assay (ELISA): the effect of different sources of rubella antigen.

Authors:  H I Thomas; P Morgan-Capner
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

3.  Immunochemical characterization of human antibodies to lymphoblastoid interferon.

Authors:  L M Thurmond; M J Reese
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

4.  Significance of IgG-Avidity in Antenatal Rubella Diagnosis.

Authors:  Olajide Olubunmi Agbede; Oluwapelumi Olufemi Adeyemi; Abdul Wahab Olanrewaju Olatinwo
Journal:  J Family Reprod Health       Date:  2013-09

Review 5.  Molecular biology of rubella virus.

Authors:  T K Frey
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.